<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-id journal-id-type="publisher-id">IPHB</journal-id><journal-id journal-id-type="publisher-id">iphb20</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6407588</article-id><article-id pub-id-type="pmid">30843752</article-id><article-id pub-id-type="doi">10.1080/13880209.2018.1557699</article-id><article-id pub-id-type="publisher-id">1557699</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The clickable activity-based probe of anti-apoptotic calenduloside E</article-title><alt-title alt-title-type="running-authors">Y. Tian et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5997-1456</contrib-id><name><surname>Tian</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref><xref ref-type="author-notes" rid="FN0001">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shan</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref><xref ref-type="author-notes" rid="FN0001">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shang</surname><given-names>Hai</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wen-Qian</given-names></name><xref ref-type="aff" rid="AF0006">
<sup>f</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Bao-Qi</given-names></name><xref ref-type="aff" rid="AF0007">
<sup>g</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xi</given-names></name><xref ref-type="aff" rid="AF0007">
<sup>g</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Xu-Dong</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Gui-Bo</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref><xref ref-type="corresp" rid="AN0002"/></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Xiao-Bo</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="aff" rid="AF0003">
<sup>c</sup>
</xref><xref ref-type="aff" rid="AF0004">
<sup>d</sup>
</xref><xref ref-type="aff" rid="AF0005">
<sup>e</sup>
</xref><xref ref-type="corresp" rid="AN0003"/></contrib><aff id="AF0001">
<label>a</label>
<institution>Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, Beijing, <country>China</country>; </aff><aff id="AF0002">
<label>b</label>
<institution>Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, Beijing, <country>China</country>; </aff><aff id="AF0003">
<label>c</label>
<institution>Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, Beijing, <country>China</country>; </aff><aff id="AF0004">
<label>d</label>
<institution>Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, Beijing, <country>China</country>; </aff><aff id="AF0005">
<label>e</label>
<institution>Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences</institution>; </aff><aff id="AF0006">
<label>f</label>
<institution>Tianjin Institute of Pharmaceutical Research</institution>, Tianjin, <country>China</country>; </aff><aff id="AF0007">
<label>g</label>
<institution>Center of Research and Development on Life Sciences and Environment Sciences, Harbin University of Commerce</institution>, Harbin, <country>China</country>
</aff></contrib-group><author-notes><fn id="FN0001"><label>*</label><p>These authors contributed equally to this work.</p></fn><corresp id="AN0001">CONTACT Xu-Dong Xu <email>xdxu@implad.ac.cn</email>; </corresp><corresp id="AN0002">Gui-Bo Sun <email>gbsun@implad.ac.cn</email>; </corresp><corresp id="AN0003">Xiao-Bo Sun <email>sunsubmit@163.com</email><institution>Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, Beijing100193, <country>China</country>.</corresp></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>07</day><month>3</month><year>2019</year></pub-date><volume>57</volume><issue>1</issue><fpage seq="18">133</fpage><lpage>139</lpage><history><date date-type="received"><day>31</day><month>8</month><year>2018</year></date><date date-type="rev-recd"><day>04</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>04</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="iphb-57-1557699.pdf"/><abstract><title>Abstract</title><p>
<bold>Context:</bold> Calenduloside E (CE), one of the primary natural products found in <italic>Aralia elata</italic> (Miq.) Seem. (Araliaceae), possesses prominent anti-apoptotic potential. A previous study found that one of the anti-apoptotic CE targets is heat shock protein 90 AB1 (Hsp90AB1) by probe CE-P, while the other targets of CE still need to be identified with more efficient probes.</p><p>
<bold>Objective:</bold> This study investigates CE analogue (CEA) as one clickable activity-based probe for use in exploring anti-apoptotic CE targets.</p><p>
<bold>Materials and methods:</bold> Pretreatment of HUVECs with CEA (1.25&#x02009;&#x003bc;M) for 8 hr, followed by ox-LDL stimulation for 24&#x02009;h. Flow cytometry analysis and JC-1 staining assays were performed The kinetic constant measurements were tested by the Biacore T200, CM5 Sensor Chip which was activated by using sulpho-NHS/EDC. Ligands were dissolved and injected with a concentration of 12.5, 6.25, 3.125, 1.56, 0.78 and 0&#x02009;&#x003bc;M.</p><p>
<bold>Results:</bold> CEA was confirmed to possess an anti-apoptotic effect. The probable targets of CE/CEA were calculated, and as one of the higher scores proteins (Fit values: 0.88/0.86), Hsp90 properly got our attention. Molecular modelling study showed that both CE and CEA could bind to Hsp90 with the similar interaction, and the docking scores (<italic>S</italic> value) were &#x02212;7.61 and &#x02212;7.33. SPR assay provided more evidence to prove that CEA can interact with Hsp90 with the KD value 11.7&#x02009;&#x000b5;M.</p><p>
<bold>Discussion and conclusions:</bold> Our results suggest that clickable probe CEA could alleviate ox-LDL induced apoptosis by a similar mechanism of anti-apoptotic CE, and afforded the possibility of identifying additional anti-apoptotic targets of CE.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd><italic>Aralia elata</italic></kwd><kwd>natural products</kwd><kwd>CE analogue</kwd><kwd>molecular modelling</kwd><kwd>SPR</kwd><kwd>Hsp90</kwd></kwd-group><funding-group><award-group><funding-source><named-content content-type="funder-name">Natural Sciences Foundation of Beijing</named-content></funding-source><award-id>7144225</award-id></award-group><award-group><funding-source><named-content content-type="funder-name">National Natural Sciences Foundation of China</named-content></funding-source><award-id>81302656</award-id><award-id>81502929</award-id></award-group><award-group><funding-source><named-content content-type="funder-name">National Science and Technology Major Project</named-content></funding-source><award-id>2015ZX09501004-001-003</award-id></award-group><award-group><funding-source><named-content content-type="funder-name">the CAMS Innovation Fund for Medical Science (CIFMS)</named-content></funding-source><award-id>2016-I2M-1-012</award-id></award-group><funding-statement>This work was supported by the Natural Sciences Foundation of Beijing [Grant No. 7144225], the National Natural Sciences Foundation of China [Grant No. 81302656 and 81502929], the National Science and Technology Major Project [Grant No. 2015ZX09501004-001-003], and the CAMS Innovation Fund for Medical Science (CIFMS) [Grant No. 2016-I2M-1-012].</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="7"/><word-count count="4284"/></counts></article-meta></front><body><sec id="s0001"><title>Introduction</title><p>Target identification of natural products is one of the most crucial aspects and greatest challenges for innovative drug R&#x00026;D. Many biologically active natural products were delayed on the steps of being candidate drug, due to insufficient information of exact functional target (Overington et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2006</xref>; Eder et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2014</xref>). Increasing evidence illustrates that chemical proteomics is a powerful strategy commonly used for identification of natural products target (Guiffant et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2007</xref>; Yi et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2012</xref>; Cui et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2015</xref>; Wang et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015</xref>, <xref rid="CIT0020" ref-type="bibr">2016</xref>). Among them, click chemistry activity-based protein profiling (CC-ABPP) strategies, as a more efficient chemical proteomic method could avoid influencing cell permeability by the bulky tag and promote the active group entering the active site (Speers and Cravatt <xref rid="CIT0014" ref-type="bibr">2009</xref>; Li et&#x000a0;al. <xref rid="CIT0005" ref-type="bibr">2012</xref>; Martell and Weerapana <xref rid="CIT0007" ref-type="bibr">2014</xref>).</p><p>Calenduloside E (CE, 1, <xref ref-type="fig" rid="F0001">Figure 1</xref>) is one of the primary natural pentacyclic triterpenoid saponins extracted from <italic>Aralia elata</italic> (Miq) Seem (Araliaceae), (AS), which is commonly employed as an antiarrhythmic, antihypertensive and antidiabetic agent in traditional Chinese medicine (Nhiem et&#x000a0;al. <xref rid="CIT0008" ref-type="bibr">2011</xref>; Wang et&#x000a0;al. <xref rid="CIT0018" ref-type="bibr">2014</xref>). We previously demonstrated that the proteomic profiling of CE targets associated with anti-apoptosis effect by using the whole probe biotin-conjugated CE analogue (BCEA, 2, <xref ref-type="fig" rid="F0001">Figure 1</xref>) in HUVEC (Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>). We also reported that CE and its analogues could provide protection to H9c2 cardiomyocytes against H<sub>2</sub>O<sub>2</sub>-induced apoptosis, most likely via anti-apoptotic mechanism (Tian, Du, et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2017</xref>, <xref rid="CIT0017" ref-type="bibr">2018</xref>). Moreover, we successfully founded that Hsp90AB1, as a familiar protein associated with anti-apoptosis effect, was proved to be one of the CE targets by a clickable CE probe (CE-P, 3, <xref ref-type="fig" rid="F0001">Figure 1</xref>) in our recent report (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). Though CE proved to be a multi-mechanism and multi-target natural product, the other targets of CE still need to be identified with more efficient probes.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>The structures of calenduloside E (CE), the clickable probe CE-P and the whole probe BCEA of CE.</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1557699_F0001_B"/></fig><p>Herein, we describe another available clickable probe CEA (<xref ref-type="fig" rid="F0002">Figure 2</xref>), which could be introduced the tag &#x02018;Biotin-azide&#x02019; to be an integral probe BCEA in the physiological environment via click chemistry reaction and avoid the steric hindrance like BCEA with bulky tag moiety. Compared with CE, the novel probe CEA exhibit a similar protective and anti-apoptotic effect in HUVEC. Virtual target fishing and molecular modelling research showed that Hsp90 might be the probable target of CE/CEA, and both CE and CEA could bind to Hsp90 with the similar mode. In addition, the SPR assay showed that CEA could interact with Hsp90. Our data revealed that CEA could also attenuate apoptosis by the similar anti-apoptotic mechanism with CE, and provided the possibility for detection and identification of more anti-apoptotic targets of CE.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>The construction of clickable probe CEA from lead compound CE.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1557699_F0002_C"/></fig></sec><sec id="s0002"><title>Materials and methods</title><p>All the reagents were used without further purification unless otherwise specified. Solvents were dried and redistilled in the usual manner prior to use. Analytical TLC was performed using silica gel HF254. Preparative column chromatography was performed with silica gel H. <sup>1</sup>H- and <sup>13</sup>C-NMR spectra were recorded on a Bruker Advance III 600&#x02009;MHz spectrometer. HRMS were obtained on a Thermo Fisher LTQ-Orbitrap XL. CE was provided by the Institute of Medicinal Plant Development (Beijing, China) (Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>). Cell culture products were purchased from Gibco BRL (Grand Island, NY).</p><sec id="s0003"><title>Chemistry</title><p>The chemical methods and data were described in our previous studies (Tian, Du, et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2017</xref>; Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>; Tian et&#x000a0;al. <xref rid="CIT0017" ref-type="bibr">2018</xref>; Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>).</p></sec><sec id="s0004"><title>Evaluation of the biological activity</title><sec id="s0005"><title>Cell preparation and culture</title><p>HUVECs were isolated from fresh human umbilical veins using 0.1% collagenase I, as previously described (Qin et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">2015</xref>). After dissociation, the cells were collected and cultured in VascuLife<sup>&#x000ae;</sup> VEGF Endothelial Cell Culture Medium (Lifeline Cell Technology, MD) supplemented with 100&#x02009;U/mL penicillin and 100&#x02009;&#x003bc;g/mL streptomycin. The cell cultures were kept in a humidified atmosphere containing 5% CO<sub>2</sub> at 37&#x000b0;C. Cells at passages 3&#x02013;7 were used in subsequent experiments. Neonatal umbilical cords were donated by the Maternal and Child Care Service Center in Beijing, China.</p></sec><sec id="s0006"><title>Cell viability assay</title><p>Cell viability was determined using the MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium, Amresco, 0973] assay as previously described (Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>). Briefly, HUVECs were plated on 96-well plates at a density of 8&#x02009;&#x000d7;&#x02009;104 cells/well and then grown at 37&#x02009;&#x000b0;C for 24&#x02009;h. The treatment group cells were pretreated with CE/CEA for 8&#x02009;h, followed by treatment with ox-LDL (80&#x02009;&#x003bc;g/mL, 24&#x02009;h), the control group was pretreated with vehicle for 8&#x02009;h then exposed without ox-LDL. To measure cell viability, 1&#x02009;mg/mL MTT assay solution was added and the plates were incubated for an additional 4&#x02009;h. The supernatant was removed and the formazan crystals were dissolved in 100&#x02009;&#x003bc;L of DMSO. Then, the absorbance was measured at 570&#x02009;nm on a microplate reader (Tecan, Switzerland). The ratio of living cells was calculated by the ratio of optical density compared with that of the normal wells.</p></sec><sec id="s0007"><title>Assessment of cell apoptosis</title><p>HUVECs were incubated with ox-LDL (80&#x02009;&#x003bc;g/mL, 24&#x02009;h) and pretreated with CEA for 8&#x02009;h prior to the apoptosis assay. Double fluorescence staining was performed using an Annexin V-FITC/PI apoptosis staining kit (Molecular Probes&#x02122;, V13241) according to the manufacturer&#x02019;s instructions to detect early apoptotic and necrotic cells. Cellular fluorescence was measured using flow cytometry with a FACS Calibur Flow Cytometer (BD Biosciences, USA).</p></sec><sec id="s0008"><title>Determination of &#x00394;&#x003a8;m</title><p>JC-1, Beyotime Biotechnology, (C2005) was used to measure the changes in mitochondrial transmembrane potential. Briefly, the HUVECs cells were harvested and washed with phosphate buffered saline (PBS). Then, the cells were stained with 2&#x02009;&#x003bc;M JC-1 working solution for 30&#x02009;min in the dark at 37&#x02009;&#x000b0;C, photographed and analyzed using an EVOS<sup>&#x000ae;</sup> FL fluorescence microscope (Thermo Fisher Scientific, USA).</p></sec><sec id="s0009"><title>Targets predicted by discovery Studio 2016</title><p>The molecular targets of CE/CEA were predicted by Discovery Studio 2016 (BIOVIA Software Inc., San Diego, CA), a software suite for performing computational analysis of data relevant to Life Sciences research (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). To predict the possible targets of CE/CEA, the Ligand Profiler protocol that maps a set of pharmacophores, including Pharma DB by default was employed. The ligands CE/CEA were prepared by the Specifying Ligands parameter protocol. After inputting all parameters, the job was run and all the results could be monitored from the Jobs Explorer.</p></sec><sec id="s0010"><title>Molecular docking</title><p>The potential interacting mode of CE/CEA with the Hsp90 protein (PDB code: 1AMW), a molecular modelling study was explored and performed by the docking program named Induced-Fit, a refinement method in another software MOE (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). To eliminate any bond length and bond angle biases, the ligands (CE/CEA) were subjected to an &#x02018;energy minimize&#x02019; prior to docking. The binding affinities &#x02018;<italic>S&#x02019;</italic> values in MOE were used to evaluate the interactions between Hsp90 and CE/CEA. The scores (binding affinities) were obtained based on the virtual calculation of various interactions of the ligands with the targeted receptor.</p></sec><sec id="s0011"><title>Surface-plasmon resonance (SPR)</title><p>The interaction detection and kinetic constant measurement of molecules and proteins were examined by the Biacore T200 System (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). CM5 Sensor Chip was activated by using sulpho-NHS/EDC chemistry in a buffer consisting of 2.7&#x02009;mM KCl 137&#x02009;mM NaCl, 0.05% (v/v) surfactant P20, pH 7.4. The chip was subsequently immobilized with the recombinant human Hsp90AB1 protein at a concentration of 37&#x02009;&#x003bc;g/mL in sodium acetate, pH 4.5 and then blocked with 1&#x02009;M ethanolamine, pH 8.0. Ligands were dissolved to 10&#x02009;mM in 100% DMSO and then 50-fold into running buffer without DMSO then diluted 2-fold by running buffer into 12.5, 6.25, 3.125, 1.56, 0.78 and 0&#x02009;&#x003bc;M before injection. The optical interference pattern was recorded as a change in optical path difference in units of nm. Data were analyzed with Biacore T200 Evaluation Software.</p></sec></sec><sec id="s0012"><title>Statistical analysis</title><p>Data are presented as the means&#x02009;&#x000b1;&#x02009;standard deviation (SD) of three independent experiments. The groups were compared using one-way ANOVA followed by Tukey's multiple comparison tests using the statistics module of Graph Pad Prism 5.0. A value of <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="s0013"><title>Results and discussion</title><sec id="s0014"><title>Chemistry</title><p>Abundant natural ursolic acid was treated with benzyl bromide (BnBr), potassium carbonate solution (K<sub>2</sub>CO<sub>3</sub>), and tetrabutyl ammonium bromide (TBAB) in dichloromethane (DCM) to produce intermediate A, in <xref ref-type="scheme" rid="SCH0001">Scheme 1</xref>. Galactosyl trichloroacetimidate was obtained from monose employing general procedures which published previously by Schmidt and Michel (<xref rid="CIT0013" ref-type="bibr">1980</xref>). Compound A coupled with galactosyl trichloroacetimidate in Lewis acidic catalytic conditions trimethylsilyl trifluoro methanesulfonate (TMSOTf) to gained intermediate B, which was subsequently hydrogenated to obtain intermediate C in existing of catalytic amount of Pd-C. Intermediate D was prepared via acylation with propargyl amine at C-28 carboxyl of CE, and deprotected benzoyl groups on the glycosyl-groups by NaOMe/MeOH solution to obtain clickable activity-based probe CEA. The chemical methods shown above, were described in our former studies which illustrated potent saponin analogues associated with cardioprotective activity (Tian, Du, et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2017</xref>; Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>; Tian et&#x000a0;al. <xref rid="CIT0017" ref-type="bibr">2018</xref>; Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>).</p><fig id="SCH0001" orientation="portrait" position="float"><label>Scheme 1.</label><caption><p>Synthesis of clickable activity-based probe CEA. Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, TBAB; (b) Galactosyl trichloroacetimidate, TMSOTf, 4&#x02009;&#x000c5; MS; (c) H<sub>2</sub>, Pd-C (10%); (d) HOBt, EDCI, Propargylamine; (e) NaOMe, MeOH.</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1557699_SCH0001_B"/></fig></sec><sec id="s0015"><title>Biological results and discussion</title><sec id="s0016"><title>Clickable probe CEA protects HUVEC against ox-LDL-mediated injury</title><p>Oxidized low-density lipoprotein (ox-LDL) leads to lesion and damage that is one pathogenetic cause for atherosclerosis generation and also can be employed for evaluating small molecules (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). In the current study, we assessed the protective potential of saponin CE and the clickable probe CEA on ox-LDL mediated cells injury. In <xref ref-type="fig" rid="F0003">Figure 3</xref>, pre-treatment of HUVECs with compounds (CE/CEA, 1.25&#x02009;&#x003bc;M) for 8&#x02009;h, then followed ox-LDL stimulation for 24&#x02009;h, could both produced prominent protective effects. Compared to ox-LDL treated group, both saponin prototype and probe could promote the viability of HUVECs, while compared to prototype CE group, clickable probe CEA group showed no significant difference on cell viability that means CEA could also keep the protective function in HUVECs.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Protective effects of CE/CEA on ox-LDL induced HUVEC injury. Cell viability of HUVEC cells incubated with 1.25&#x02009;&#x003bc;M concentration of CE/CEA for 8&#x02009;h. Pretreatment with probe could significantly alleviate ox-LDL-induced cell damage. <sup>##</sup>
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus control, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus ox-LDL, *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 versus ox-LDL.</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1557699_F0003_B"/></fig></sec><sec id="s0017"><title>Clickable probe CEA attenuates ox-LDL-treated apoptosis</title><p>Generally occurring during the early stage of apoptosis, phosphatidylserine (PS) that exposure on the external surface of cytomembrane can be detected by flow cytometry with Annexin V&#x02013;PI double staining (Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>). In the present research, compared with the control group, apoptotic cells were remarkably increased after ox-LDL exposure, which was significantly descended by treatment with CEA group (<xref ref-type="fig" rid="F0004">Figure 4(A)</xref>). As an early event in the apoptotic cascade, the disruption of mitochondrial membrane potential (&#x00394;&#x003a8;m) could be detected by using JC-1 assay. Ox-LDL treated group showed an enhancement in green fluorescence intensity, while the CEA treated group exhibited more red fluorescence, indicating that the clickable probe CEA could suppress the ox-LDL mediated mitochondrial dissipation and apoptosis (<xref ref-type="fig" rid="F0004">Figure 4(B)</xref>).</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>CEA attenuates ox-LDL mediated HUVEC apoptosis. (A) Annexin V-PI double staining was employed for detecting a protective effect of CEA; (B) JC-1 staining was employed for detecting mitochondrial membrane potential changes in CEA-treated HUVECs during ox-LDL mediated apoptosis.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1557699_F0004_C"/></fig></sec><sec id="s0018"><title>Target prediction of the clickable probe CEA and CE</title><p>Virtual target fishing strategy has been a useful technique for prediction and revelation of the potential targets of bioactive natural products (Rollinger et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2009</xref>; Lomenick et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2011</xref>). Therefore, the Discovery Studio 2016 software was employed for predicting the probable molecular targets of CE and its clickable probe CEA. Our findings showed that CE and the probe could modulate a series of functional targets. According to the Fit values data arranged from higher to lower, the top six predicted targets of CE and CEA were chosen (<xref ref-type="fig" rid="F0005">Figure 5</xref>). Among them, heat shock protein 90 (Hsp90), an apoptosis-related significant target that existed higher on both the lists of predicted targets names of CE and CEA was aroused our attention.</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>The predicted targets names of CE and CEA.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1557699_F0005_C"/></fig><p>Previous studies have demonstrated that the proteomic profiling of CE targets associated with anti-apoptosis effect, likely through the interaction of the glycosyl group of saponin with the apoptosis-associated proteins such as Hsp90 (Tian, Wang, et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2017</xref>; Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). In this current research, probable targets which have crucial relevance with the endothelial protective effects of CE were predicted through virtual target fishing technique. Among the top six predicted candidates with higher Fit values, both the lists of two compounds involved Hsp90 that one of the familiar apoptosis-related targets. On top of that, Hsp90 has been proved to be one of the CE targets in our recent report. Therefore, Hsp90 was inferred as one of the apoptosis-related targets of both CE and its probe CEA but still need more experiments to identify.</p></sec><sec id="s0019"><title>Molecular modelling of the anti-apoptotic targets of CE and clickable probe CEA</title><p>Molecular modelling is a commonly and frequently applied technique to predict the specific positioning of a ligand in the active site of a protein (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). Due to one of the apoptosis-related targets was predicted as Hsp90, molecular docking was performed to investigate the possible binding mode of probe CEA to protein Hsp90 compared with CE.</p><p>Molecular Operating Environment (MOE; Chemical Computing Group, Montreal, Quebec, Canada) software package was employed for simulating the possible interaction sites between the predicted target Hsp90 receptor (PDB ID: 1AMW) and small molecules CE/CEA. The estimated values always exhibited in the &#x02018;<italic>S&#x02019;</italic> field, and these <italic>S</italic> values were ranked through the scores from GBVI/WSA binding free energy calculation of the binding action of CE/CEA with Hsp90 protein. The <italic>S</italic> value of CE was &#x02212;7.61, while CEA was &#x02212;7.33, a little weaker than CE. Molecular docking results indicated that both CE and CEA can bind into the Hsp90 active pocket, which located to the N-terminal domain.</p><p>As shown in <xref ref-type="fig" rid="F0006">Figure 6(A)</xref>, the glycosyl moieties of saponin CE could form three significant hydrogen bonds with critical amino acid residues Asn 37 and Asp 79, while the glycosyl moieties of probe CEA could come out two (<xref ref-type="fig" rid="F0006">Figure 6(B)</xref>). This simulated data also illustrated and explained that the above cell viability and cell apoptosis assay results and the active moiety of CE might be located in the glycosyl group but not carboxyl.</p><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Molecular docking of CE/CEA binding with Hsp90. (A) 2D ligand interaction diagram of CE and Hsp90; (B) CEA and Hsp90. (C) 3D poses of CE/CEA binding with Hsp90.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1557699_F0006_C"/></fig><p>In <xref ref-type="fig" rid="F0006">Figure 6(C)</xref>, both CE (grey) and CEA (green) could bind in the active pocket of Hsp90, the glycosyl groups were responsible essential for binding to amino acid residues Asn 37 and Asp 79. Compared to prototype CE, the probe CEA showed a similar binding pose in the active site of the protein, and its propargyl segment (in red frame) that exposing external of the pocket was constructed for introducing the biotin or fluorescence tags conveniently via &#x02018;clicking chemistry&#x02019; reaction. Molecular modeling assay found that both CE and CEA could bind with Hsp90 with the similar interaction mode, and it might be the indirect evidence that CE/CEA could affect the function of Hsp90, and CEA could be a useful probe for searching the other targets of CE.</p></sec><sec id="s0020"><title>SPR assay analysis of clickable probe CEA binding to apoptosis-related protein Hsp90</title><p>Optical biosensors based on surface plasmon resonance (SPR) detection emerged as an efficient approach to obtain the interactional information about the binding of small ligands to target proteins. The detection principle, based solely on refractivity at the surface of a sensor chip, does not require any pre-labelling of molecules, avoiding time- and money-consuming steps, which could also potentially affect the interaction (Cannon et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2004</xref>; Nguyen et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2015</xref>).</p><p>Based on our previous research, one of the targets of anti-apoptotic CE was proved to be Hsp90AB1 by another clickable probe CE-P and further confirmed through SPR assay. Therefore, Biacore T200 instrument (General Electric Company, Boston, MA, USA) was employed for confirming the interaction situation and binding affinity of CEA with Hsp90AB1. As shown in <xref ref-type="fig" rid="F0007">Figure 7</xref>, SPR data analysis revealed that CEA could bind with Hsp90AB1 in a dose-dependent manner. KD value of CEA binding to Hsp90AB1 was 11.7&#x02009;&#x003bc;M, while CE was 2.43&#x02009;&#x003bc;M and CE-p was 23.4&#x02009;&#x003bc;M (Wang et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2018</xref>). By means of SPR analysis results, we found that CEA (11.7&#x02009;&#x003bc;M) showed a relatively weaker affinity than CE (2.43&#x02009;&#x003bc;M) and a slightly better affinity than another clickable probe CE-p (23.4&#x02009;&#x003bc;M), and still held capacity binding with Hsp90AB1. This result showed that CEA, compared to previous probe CE-p, could be a more efficient clickable probe of CE, and could provide the possibility for the fishing and identification of other anti-apoptotic targets of CE.</p><fig id="F0007" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>SPR analyses of CEA binding to Hsp90AB1.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1557699_F0007_C"/></fig></sec></sec></sec><sec id="s0021"><title>Conclusions</title><p>In summary, our present research indicates that a clickable activity-based probe CEA and its prototype CE showed similar endothelial protective and anti-apoptotic potential with ox-LDL treated HUVEC injury. Through virtual target fishing, molecular modelling and SPR affinity kinetic assay, our data reveal that anti-apoptotic mechanism contributes to the protective effect of CEA and CE, at least in part, by the similar anti-apoptotic target such as Hsp90. As an efficient clickable probe, CEA could provide the basis for the further identification of the other anti-apoptotic targets of CE. The related targets fishing experiments are ongoing and will be described in subsequent reports.</p></sec></body><back><sec id="s0022"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cannon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Papalia</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Navratilova</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Worthy</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Stephen</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Marchesini</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Casper</surname><given-names>DH</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2004</year>
<article-title>Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology</article-title>. <source>Anal. Biochem</source>. <volume>330</volume>:<fpage>98</fpage>&#x02013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">15183767</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>GZ</given-names></name>, <name name-style="western"><surname>Shan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>IK</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>GPH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YQ</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Hoi</surname><given-names>MPM</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SMY</given-names></name></person-group>
<year>2015</year>
<article-title>Identification of disulfide isomerase ERp57 as a target for small molecule cardioprotective agents</article-title>. <source>RSC Adv</source>. <volume>5</volume>:<fpage>74605</fpage>&#x02013;<lpage>74610</lpage>.</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Eder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sedrani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wiesmann</surname><given-names>C</given-names></name></person-group>
<year>2014</year>
<article-title>The discovery of first-in-class drugs: origins and evolution</article-title>. <source>Nat Rev Drug Discov</source>. <volume>13</volume>:<fpage>577</fpage>&#x02013;<lpage>587</lpage>.<pub-id pub-id-type="pmid">25033734</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Guiffant</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tribouillard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gug</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Galons</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Meijer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Blondel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bach</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</article-title>. <source>Biotechnol J</source>. <volume>2</volume>:<fpage>68</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">17225251</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Overkleeft</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Florea</surname><given-names>BI</given-names></name></person-group>
<year>2012</year>
<article-title>Activity-based protein profiling: an enabling technology in chemical biology research</article-title>. <source>Curr Opin Chem Biol</source>. <volume>16</volume>:<fpage>227</fpage>&#x02013;<lpage>233</lpage>.<pub-id pub-id-type="pmid">22325363</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lomenick</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Identification of direct protein targets of small molecules</article-title>. <source>ACS Chem Biol</source>. <volume>6</volume>:<fpage>34</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">21077692</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Martell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weerapana</surname><given-names>E</given-names></name></person-group>
<year>2014</year>
<article-title>Applications of copper-catalyzed click chemistry in activity-based protein profiling</article-title>. <source>Molecules</source>. <volume>19</volume>:<fpage>1378</fpage>&#x02013;<lpage>1393</lpage>.<pub-id pub-id-type="pmid">24473203</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nhiem</surname><given-names>NX</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Kiem</surname><given-names>PV</given-names></name>, <name name-style="western"><surname>Minh</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Thu</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Tai</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Quang</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YH</given-names></name></person-group>
<year>2011</year>
<article-title>Oleanane-type triterpene saponins from the bark of <italic>Aralia elata</italic> and their NF-&#x003ba;B inhibition and PPAR activation signal pathway</article-title>. <source>Bioorganic Med Chem Lett</source>. <volume>21</volume>:<fpage>6143</fpage>&#x02013;<lpage>6147</lpage>.</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>M</given-names></name></person-group>
<year>2015</year>
<article-title>Surface plasmon resonance: a versatile technique for biosensor applications</article-title>. <source>Sensors (Basel, Switzerland)</source>. <volume>15</volume>:<fpage>10481</fpage>&#x02013;<lpage>10510</lpage>.</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Overington</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>AL-Lazikani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>AL</given-names></name></person-group>
<year>2006</year>
<article-title>How many drug targets are there?</article-title>
<source>Nat Rev Drug Discov</source>. <volume>5</volume>:<fpage>993</fpage>&#x02013;<lpage>996</lpage>.<pub-id pub-id-type="pmid">17139284</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>XB</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>JX</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2015</year>
<article-title>Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: an insight into PI3K/Akt activation and STAT3 signaling pathways</article-title>. <source>Vasc Pharmacol</source>. <volume>70</volume>:<fpage>23</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rollinger</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schuster</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Danzl</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schwaiger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Markt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schmidtke</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gertsch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Raduner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wolber</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Langer</surname><given-names>T</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2009</year>
<article-title>
<italic>In silico</italic> target fishing for rationalized ligand discovery exemplified on constituents of <italic>Ruta graveolens</italic>
</article-title>. <source>Planta Medica</source>. <volume>75</volume>:<fpage>195</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">19096995</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>J</given-names></name></person-group>
<year>1980</year>
<article-title>Facile synthesis of &#x003b1;- and &#x003b2;-<italic>O</italic>-glycosyl imidates: preparation of glycosides and disaccharides</article-title>. <source>Angewandte Chemie Int Ed</source>. <volume>19</volume>:<fpage>731</fpage>&#x02013;<lpage>732</lpage>.</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Speers</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2009</year>
<article-title>Activity-based protein profiling (ABPP) and click chemistry (CC)-ABPP by MudPIT mass spectrometry</article-title>. <source>Curr Protoc Chem Biol</source>. <volume>1</volume>:<fpage>29</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">21701697</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>XB</given-names></name></person-group>
<year>2017</year>
<article-title>The proteomic profiling of calenduloside E targets in HUVEC: design, synthesis and application of biotinylated probe BCEA</article-title>. <source>RSC Adv</source>. <volume>7</volume>:<fpage>6259</fpage>&#x02013;<lpage>6265</lpage>.</mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>ZH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>BQ</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shan</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>GB</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2017</year>
<article-title>Calenduloside E analogues protecting H9c2 cardiomyocytes against H<sub>2</sub>O<sub>2</sub>-induced apoptosis: design, synthesis and biological evaluation</article-title>. <source>Front Pharmacol</source>. <volume>8</volume>:<fpage>862</fpage>.<pub-id pub-id-type="pmid">29218010</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>ZH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>WQ</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>BQ</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>GX</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>ZN</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XD</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2018</year>
<article-title>Semisynthesis and biological evaluation of oleanolic acid 3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucuronopyranoside derivatives for protecting H9c2 cardiomyoblasts against H<sub>2</sub>O<sub>2</sub>-induced injury</article-title>. <source>Molecules</source>. <volume>23</volume>:<fpage>44</fpage>.</mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>XP</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>XB</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of the total saponins of <italic>Aralia elata</italic> (Miq) Seem on cardiac contractile function and intracellular calcium cycling regulation</article-title>. <source>J Ethnopharmacol</source>. <volume>155</volume>:<fpage>240</fpage>&#x02013;<lpage>247</lpage>.<pub-id pub-id-type="pmid">24875646</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>He</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>QS</given-names></name></person-group>
<year>2015</year>
<article-title>Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP)</article-title>. <source>Sci Rep</source>. <volume>5</volume>:<fpage>7896</fpage>&#x02013;<lpage>7907</lpage>.<pub-id pub-id-type="pmid">25600173</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>ZC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tannenbaum</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>QS</given-names></name></person-group>
<year>2016</year>
<article-title>
<italic>In situ</italic> proteomic profiling of curcumin targets in HCT116 colon cancer cell line</article-title>. <source>Sci Rep</source>. <volume>6</volume>:<fpage>22146</fpage>&#x02013;<lpage>22153</lpage>.<pub-id pub-id-type="pmid">26915414</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>GB</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2018</year>
<article-title>Targets fishing and identification of calenduloside E as Hsp90AB1: design, synthesis, and evaluation of clickable activity-based probe</article-title>. <source>Front Pharmacol</source>. <volume>9</volume>:<fpage>532</fpage>.<pub-id pub-id-type="pmid">29875664</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Geldenhuys</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pink</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Dowlati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>B</given-names></name></person-group>
<year>2012</year>
<article-title>Identification of a class of novel tubulin inhibitors</article-title>. <source>J Med Chem</source>. <volume>55</volume>:<fpage>3425</fpage>&#x02013;<lpage>3435</lpage>.<pub-id pub-id-type="pmid">22435708</pub-id></mixed-citation></ref></ref-list></back></article>